Financials Jin Medical International Ltd.
Equities
ZJYL
KYG5140V1124
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | -8.26% | -13.29% | -75.81% |
Valuation
Fiscal Period: September | 2023 |
---|---|
Capitalization 1 | 182.5 |
Enterprise Value (EV) 1 | 169.9 |
P/E ratio | 59 x |
Yield | - |
Capitalization / Revenue | 9.21 x |
EV / Revenue | 8.57 x |
EV / EBITDA | 54.9 x |
EV / FCF | -108,088,439 x |
FCF Yield | -0% |
Price to Book | 7.61 x |
Nbr of stocks (in thousands) | 155,947 |
Reference price 2 | 1.170 |
Announcement Date | 4/26/24 |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 20.91 | 20.37 | 16.19 | 20.76 | 19.19 | 19.82 |
EBITDA 1 | 4.596 | 4.753 | 2.685 | 2.978 | 2.493 | 3.093 |
EBIT 1 | 4.228 | 4.404 | 2.355 | 2.632 | 2.131 | 2.867 |
Operating Margin | 20.22% | 21.62% | 14.54% | 12.67% | 11.1% | 14.47% |
Earnings before Tax (EBT) 1 | 4.299 | 4.127 | 2.353 | 2.88 | 2.743 | 3.222 |
Net income 1 | 3.682 | 3.648 | 2.206 | 2.632 | 2.707 | 2.878 |
Net margin | 17.61% | 17.91% | 13.62% | 12.67% | 14.1% | 14.52% |
EPS 2 | 0.009204 | 0.009118 | 0.005514 | 0.006579 | 0.0200 | 0.0198 |
Free Cash Flow | - | -0.3768 | 1.214 | 4.073 | 1.345 | -1.572 |
FCF margin | - | -1.85% | 7.5% | 19.62% | 7.01% | -7.93% |
FCF Conversion (EBITDA) | - | - | 45.23% | 136.77% | 53.94% | - |
FCF Conversion (Net income) | - | - | 55.04% | 154.77% | 49.68% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 12/28/20 | 12/28/20 | 9/24/21 | 2/4/22 | 2/24/23 | 4/26/24 |
Balance Sheet Analysis
Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 1.74 | 0.47 | 0.19 | 5.73 | 7.07 | 12.6 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | -0.38 | 1.21 | 4.07 | 1.34 | -1.57 |
ROE (net income / shareholders' equity) | - | 37% | 20.5% | 21.2% | 18.5% | 14.7% |
ROA (Net income/ Total Assets) | - | 14.1% | 7.15% | 7.7% | 6.22% | 6.66% |
Assets 1 | - | 25.87 | 30.86 | 34.18 | 43.54 | 43.24 |
Book Value Per Share 2 | 0.0200 | 0.0300 | 0.0300 | 0.0400 | 0.1100 | 0.1500 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0.0100 | 0.0400 | 0.0400 |
Capex 1 | 0.19 | 0.07 | 0.14 | 0.04 | 0.04 | 0.11 |
Capex / Sales | 0.9% | 0.36% | 0.88% | 0.21% | 0.21% | 0.57% |
Announcement Date | 12/28/20 | 12/28/20 | 9/24/21 | 2/4/22 | 2/24/23 | 4/26/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-75.81% | 470M | |
+10.10% | 27.85B | |
-30.75% | 3.09B | |
+35.19% | 2.66B | |
-18.85% | 2.44B | |
+6.85% | 2.24B | |
+33.33% | 2.05B | |
-4.71% | 2.02B | |
+34.05% | 1.35B | |
+3.25% | 1.33B |
- Stock Market
- Equities
- ZJYL Stock
- Financials Jin Medical International Ltd.